-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to a new study by scientists from the National Institutes of Health and their colleagues, after the main vaccine series of rhesus monkeys significantly increased the level of neutralizing antibodies against all known SARS-CoV-2 variants, Rhesus monkeys were injected with an enhanced dose of the new coronavirus mRNA-1273 vaccine for about 6 months
The researchers also determined that the mRNA-1273 vaccine developed against the original SARS-CoV-2 virus and the slightly modified version of the Beta variant virus are the same in terms of enhancing antibody response and protection
This study was conducted 6 months ago, when the SARS-CoV-2 Beta mutation was a major problem
The scientists wrote that in humans, the mRNA-1273 booster vaccine may increase the protection time and effectiveness of any spreading SARS-CoV-2 variants (including Delta virus) from upper and lower respiratory tract infections
Original search:
K Corbettet al .